Lithium succinate

Lithium succinate (C4H4Li2O4), the dilithium salt of succinic acid, is a drug used in the treatment of seborrhoeic dermatitis[1] and proposed for the treatment of anogenital warts.[2]

Lithium succinate
Clinical data
Other namesLithium succinate dibasic
AHFS/Drugs.comMonograph
ATC code
Identifiers
IUPAC name
  • Dilithium butanedioate
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
ChEMBL
ECHA InfoCard100.163.153
Chemical and physical data
FormulaC4H4Li2O4
Molar mass129.95 g·mol−1
3D model (JSmol)
SMILES
  • [Li+].[Li+].[O-]C(=O)CCC([O-])=O
InChI
  • InChI=1S/C4H6O4.2Li/c5-3(6)1-2-4(7)8;;/h1-2H2,(H,5,6)(H,7,8);;/q;2*+1/p-2 Y
  • Key:WAHQBNXSPALNEA-UHFFFAOYSA-L Y
  (verify)

References
  1. Leeming JP (1993). "Use of topical lithium succinate in the treatment of seborrhoeic dermatitis". Dermatology. 187 (2): 149–50. doi:10.1159/000247228. PMID 8358107.
  2. Ward KA, Armstrong KD, Maw RD, Winther MD, Gilburt SJ, Dinsmore WW (1997). "A pilot study to investigate the treatment of anogenital warts with Topical Lithium Succinate cream (8% lithium succinate, 0.05% zinc sulphate)". International Journal of STD & AIDS. 8 (8): 515–7. doi:10.1258/0956462971920677. PMID 9259500. S2CID 23095115.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.